TY - JOUR
T1 - Pilot study for the evaluation and adaptation of a Four Item-Acne-Scar Risk Assessment Tool (4-ASRAT)
T2 - A resource to estimate the risk of acne-induced scars
AU - Estrella Porter, Jorge
AU - Guillemot, Jonathan
AU - Camacho, Mikaela
AU - Viteri, María Isabel
AU - Aguilar, Katherine
AU - Belhadi, Drifa
AU - Bettoli, Vincenzo
AU - Buestán, Anita del Rocío
AU - Dréno, Brigitte
AU - Endara, Pablo
AU - Layton, Alison
AU - Machado, Nelly
AU - Mateus, Rosa
AU - Tan, Jerry
AU - Terán, Enrique
AU - Yépez, Paola
N1 - Publisher Copyright:
© 2020 Estrella Porter J et al.
PY - 2020
Y1 - 2020
N2 - Background: Acne-induced scarring is associated with a similar burden as acne, i.e. diminished quality of life, and may be avoided if patients receive appropriate and timely acne treatment. In 2017, a four item-Acne-Scar Risk Assessment Tool (4-ASRAT) was designed by Tan et al. to categorise patients with acne into lower-risk or higher-risk for acne scarring. Its applicability outside the initial study population (France, Brazil and United States) remains to be determined. Methods: A study protocol was developed to create a systematic approach for validating and adapting 4-ASRAT to different populations, Ecuador in this case. The protocol was reviewed by 11 local and international dermatologists and pilot-tested in an Ecuadorian population using a sample of 10 participants who currently had or had had acne. Feedback from the pilot study was used to improve the study protocol. The results of the pilot study are included here, and the final study protocol is available as extended data. Results: The protocol proved to be applicable. Images taken of participants were a valuable resource for dermatological evaluation about the presence or absence of acne scars. Tangential light is necessary for this evaluation. Although dermatological assessments varied, we concluded that assessment by three local dermatologists for each participant was adequate for reaching a consensus on the presence or absence of acne scars. Conclusions: Considering the morbidity related to acne and acne scars, tools designed as prevention that alert patients about risk of developing scarring are necessary. The proposed protocol shows a feasible way of validating and adapting 4-ASRAT to different populations.
AB - Background: Acne-induced scarring is associated with a similar burden as acne, i.e. diminished quality of life, and may be avoided if patients receive appropriate and timely acne treatment. In 2017, a four item-Acne-Scar Risk Assessment Tool (4-ASRAT) was designed by Tan et al. to categorise patients with acne into lower-risk or higher-risk for acne scarring. Its applicability outside the initial study population (France, Brazil and United States) remains to be determined. Methods: A study protocol was developed to create a systematic approach for validating and adapting 4-ASRAT to different populations, Ecuador in this case. The protocol was reviewed by 11 local and international dermatologists and pilot-tested in an Ecuadorian population using a sample of 10 participants who currently had or had had acne. Feedback from the pilot study was used to improve the study protocol. The results of the pilot study are included here, and the final study protocol is available as extended data. Results: The protocol proved to be applicable. Images taken of participants were a valuable resource for dermatological evaluation about the presence or absence of acne scars. Tangential light is necessary for this evaluation. Although dermatological assessments varied, we concluded that assessment by three local dermatologists for each participant was adequate for reaching a consensus on the presence or absence of acne scars. Conclusions: Considering the morbidity related to acne and acne scars, tools designed as prevention that alert patients about risk of developing scarring are necessary. The proposed protocol shows a feasible way of validating and adapting 4-ASRAT to different populations.
KW - Acne
KW - Acne scars
KW - Prevention tool
KW - Risk factors
KW - Scarring
KW - Scarring prevention
UR - http://www.scopus.com/inward/record.url?scp=85089774344&partnerID=8YFLogxK
U2 - 10.12688/f1000research.23737.1
DO - 10.12688/f1000research.23737.1
M3 - Artículo
C2 - 32850122
AN - SCOPUS:85089774344
SN - 2046-1402
VL - 9
JO - F1000Research
JF - F1000Research
M1 - 651
ER -